SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-019415
Filing Date
2021-04-19
Accepted
2021-04-19 16:15:43
Documents
7
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A rgnx-def14a_20210604.htm DEF 14A 1619099
2 GRAPHIC gutqqlya10pl000003.jpg GRAPHIC 29686
3 GRAPHIC gutqqlya10pl000001.jpg GRAPHIC 21687
4 GRAPHIC gutqqlya10pl000006.jpg GRAPHIC 267336
5 GRAPHIC gutqqlya10pl000002.jpg GRAPHIC 3038
6 GRAPHIC gutqqlya10pl000005.jpg GRAPHIC 606083
7 GRAPHIC gutqqlya10pl000004.jpg GRAPHIC 112074
  Complete submission text file 0001564590-21-019415.txt   3052522
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37553 | Film No.: 21834787
SIC: 2836 Biological Products, (No Diagnostic Substances)